The federal government has ended a Medicare program that helped low-income enrollees pay for prescription drugs, a move that is expected to raise out-of-pocket costs for some of the most financially vulnerable people on the program. The termination affects the Low Income Subsidy program, often called Extra Help, which covered premiums, deductibles, and copays for qualifying Medicare Part D enrollees.
According to a report by Spectrum News, the program had provided financial assistance to millions of Medicare beneficiaries who met income and asset thresholds. Those enrollees used the subsidy to reduce or eliminate costs that would otherwise make prescription drugs unaffordable.
Medicare Part D is the component of Medicare that covers prescription drugs. Enrollees typically pay monthly premiums to private insurers who administer the plans, along with deductibles and cost-sharing at the pharmacy. For beneficiaries with limited incomes, those costs can consume a significant portion of fixed monthly budgets from Social Security or other retirement income.
The Low Income Subsidy program was designed specifically to bridge that gap. Qualifying enrollees received varying levels of assistance depending on their income and assets, with the lowest-income enrollees receiving the most comprehensive coverage.
The end of the program raises questions about what options remain available to affected enrollees. Some may qualify for both Medicare and Medicaid, a status known as dual eligibility, which carries its own set of drug cost protections. Others may need to seek assistance through other federal or state programs, or through pharmaceutical manufacturers that offer their own patient assistance programs.
The decision is part of a broader set of policy changes at the federal level affecting Medicare and Medicaid. The Trump administration has moved to reduce federal spending across several health programs, and the drug subsidy elimination is among the more direct changes to affect individual beneficiaries at the pharmacy counter.
The timing of the change matters for current enrollees. Medicare Part D plan selections and subsidy applications are typically tied to annual enrollment periods, meaning that beneficiaries who lose the subsidy mid-year may have limited options to adjust their coverage until the next open enrollment window.
Advocacy groups that represent older Americans and low-income patients have raised concerns about the impact on people who depend on the subsidy to manage chronic conditions. Medications for diabetes, heart disease, and other long-term conditions can carry significant costs without assistance, and missed doses due to cost are associated with worse health outcomes.
The federal government has not announced a replacement program at this time.
